TRIP13 interference inhibits the proliferation and metastasis of thyroid cancer cells through regulating TTC5/p53 pathway and epithelial-mesenchymal transition related genes expression-Reference-Cited by-同舟云学术

TRIP13 interference inhibits the proliferation and metastasis of thyroid cancer cells through regulating TTC5/p53 pathway and epithelial-mesenchymal transition related genes expression

Published:2019-12 Issue: Volume:120 Page:109508
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Yu Leitao,Xiao Yong,Zhou Xiang,Wang Jun,Chen Sunqiang,Peng Tangyao,Zhu Xingen

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference35 articles.

1. Clinical practice;Burman;New Engl J Med.,2015

2. Thyroid cancer mortality and incidence: a global overview;La Vecchia;Int. J. Cancer,2015

3. Increasing incidence of thyroid cancer in Shanghai, China, 1983-2007;Wang;Asia. J. Public Health,2015

4. Thyroid cancer;Ron,2006

5. TRIP13 is a protein-remodeling AAA+ATPase that catalyzes MAD2 conformation switching;Ye;eLife,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TRIP13 − a potential drug target in cancer pharmacotherapy;Bioorganic Chemistry;2024-10

2. A new method for network bioinformatics identifies novel drug targets for mucinous ovarian carcinoma;NAR Genomics and Bioinformatics;2024-07-02

3. Gastric Cancer Biomarker Candidates Identified by Machine Learning and Integrative Bioinformatics: Toward Personalized Medicine;OMICS: A Journal of Integrative Biology;2023-06-01

4. TRIP13 overexpression promotes gefitinib resistance in non‑small cell lung cancer via regulating autophagy and phosphorylation of the EGFR signaling pathway;Oncology Reports;2023-03-08

5. TRIP13 as a prognostic marker and its correlation with clinicopathological features in human cancers: a meta-analysis;2022-12-07